Softgel Capsules Market Size Worth $10.69 Billion by 2030 | CAGR: 9.2%

Softgel Capsules Market Size Worth $10.69 Billion by 2030 | CAGR: 9.2%

The global softgel capsules market size is expected to reach USD 10.69 billion by 2030 according to a new study by Polaris Market Research. The report “Softgel Capsules Market Share, Size, Trends, Industry Analysis Report, By Type (Gelatin-based/Animal-based, Non-animal-based), By Application, By Manufacturers, By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.


The rising penetration of the developing technologies, as well as escalating geriatric population, are the major driving factors for the industry growth. Besides, increasing incidences of the diseases, along with the growing awareness for the availability of softgel capsules, is accelerating the market development. Besides, the various technological developments lead the production of the vegetarian softgel capsules and also present the flawless creation of the product is augmenting the industry growth across the globe.


The nutraceutical segment is holding the highest share in the global industry in 2020 leading to the segment demand. The increasing number of manufacturing houses, rising responsiveness for the health supplements in emerging countries, and surge in sales because of the COVID-19 pandemic is propelling the segment demand globally. Whereas, the cosmeceutical companies’ segment is likely to rise at a healthy rate in the foreseen years due to the increasing requirements for hair and skin care products, which, in turn, boost the segment growth in impending years.


Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:


The growing numbers of clinical trials are supporting the adoption of softgels pills, which may positively stimulate the industry demand. This clinical trial helps in evaluating the proficiencies of soft gelatin tablets during the treatment of some diseases. For instance, in August 2018, a clinical study was sponsored by InnoPharmax Inc. with the aim of assessing the safety and acceptability of D07001 softgel among the patients who complete first-line chemotherapy or combined chemo-radiotherapy (CCRT) for biliary tract cancer. Thereby, these factors are fostering the penetration of the softgels capsules, which may spur the market growth in the approaching years.


Market participants such as Capsugel, Captek, Aenova, Catalent, Eurocaps, Fuji Capsules Co Ltd, Elnova Pharma, Guangdong Yichao Biological Co., Ltd, Patheon, Procaps Laboratories, Sirio Pharma, Hunan ER-KANG Pharmaceutical Co Ltd, Soft gel Technologies Inc are some of the key players operating in the global market.


There are numerous market competitors who are introducing various new products for gaining a prominent position across the industry. For instance, in July 2021, the Aenove Group publicized the initiation of its new bottling and canning line for the soft gelatin tablets at Cornu, Romania. Accordingly, this commencement will assist the company to increase their capacity of the packaging departments with bottles and can, along with this set-up is also a one-stop-shop for the manufacturing & packaging of soft capsules in every general variation.


Polaris Market Research has segmented the softgel capsules market report on the basis of type, application, manufacturers, and region:


Softgel Capsules, Type Outlook (Revenue - USD Billion, 2018 - 2030)

  • Gelatin based/Animal-based
  • Non-animal based

 Softgel Capsules, Application Outlook (Revenue - USD Billion, 2018 - 2030)

  • Antacid and anti-flatulent preparations
  • Anti-anemic preparations
  • Anti-inflammatory drugs
  • Antibiotic and antibacterial drugs
  • Cough and cold preparations
  • Health supplement
  • Vitamin and dietary supplement
  • Pregnancy

 Softgel Capsules, Manufacturers Outlook (Revenue - USD Billion, 2018 - 2030)

  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Cosmeceutical Companies
  • Contract Manufacturing Organization

 Softgel Capsules, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

  • North America
    • U.S
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • Australia
    • Indonesia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa